| 產(chǎn)品編號 |
D51115 |
| 英文名稱 |
BLU-9931
|
| 中文名稱 |
|
| 別 名 |
blu9931; 2-Propenamide, N-[2-[[6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-quinazolinyl]amino]-3-methylphenyl]-; N-(2-{[6-(2,6-Dichloro-3,5-dimethoxyphenyl)-2-quinazolinyl]amino}-3-methylphenyl)acrylamide; BLU-9931; 1538604-68-0; FGFR4抑制劑 |
| 克 隆 號 |
|
| CAS |
1538604-68-0 |
| 理論分子量 |
509.38 kDa |
| 檢測分子量 |
|
| 性 狀 |
Lyophilized |
| 保存條件 |
Store in dry, dark place for one year. |
| 注意事項 |
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 產(chǎn)品介紹 |
BLU-9931 is a potent and irreversible small-molecule inhibitor of FGFR4, as a targeted therapy to treat patients with HCC whose tumors have an activated FGFR4 signaling pathway. BLU-9931 is exquisitely selective for FGFR4 versus other FGFR family members and all other kinases. BLU-9931 shows remarkable antitumor activity in mice bearing an HCC tumor xenograft that overexpresses FGF19 due to amplification as well as a liver tumor xenograft that overexpresses FGF19 mRNA but lacks FGF19 amplification. Approximately one third of patients with HCC whose tumors express FGF19 together with FGFR4 and its coreceptor klotho β (KLB) could potentially respond to treatment with an FGFR4 inhibitor.
|
|
|
